Company Comparison
Genfit vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Genfit | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Loos, France | San Diego |
| Founded | 1999 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series A |
| Total Funding | $400M | $48M |
| Valuation | — | — |
What They Build
Genfit
French biopharmaceutical company developing therapeutic and diagnostic solutions for metabolic and liver diseases, including NASH.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Genfit
AI Therapeutics
No investors listed.
Sector Overlap
Both Genfit and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.